Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BICO Group AB Class B ( (SE:BICO) ) has provided an announcement.
BICO Group AB has fully repaid its outstanding convertible bonds, totaling SEK 1,008 million in principal, at par value on their scheduled maturity date, leaving no remaining bonds under the relevant ISIN. The repayment, combined with the company’s recent issuance of EUR 40 million in senior secured bonds, strengthens BICO’s balance sheet and financial preparedness, supporting its strategic position as a key lab automation provider to global pharma and biotech customers.
The most recent analyst rating on (SE:BICO) stock is a Hold with a SEK16.00 price target. To see the full list of analyst forecasts on BICO Group AB Class B stock, see the SE:BICO Stock Forecast page.
More about BICO Group AB Class B
BICO Group AB is a lab automation partner serving the pharmaceutical and biotech industries, providing selected workflows that support the automation of life science laboratories. With more than 53,600 instruments installed across over 65 countries and used in over 3,500 labs, including the world’s top 20 pharma companies, BICO operates through its Lab Automation and Life Science Solutions segments and is listed on Nasdaq Stockholm’s Mid-Cap market.
Average Trading Volume: 228,422
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.19B
See more data about BICO stock on TipRanks’ Stock Analysis page.